ArticleJournal of the American Heart Association2022
SGLT2 Inhibitors-A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling.
Takashi Yagi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.